Biota Pharmaceuticals, Inc. 4/A
4/A · Biota Pharmaceuticals, Inc. · Filed Jun 15, 2015
Insider Transaction Report
Form 4/AAmended
Fox James
Director
Transactions
- Purchase
Common stock
2015-06-10$2.03/sh+70,000$142,100→ 100,614 total(indirect: Penashe Holdings Pty Ltd.)
Holdings
- 8,700
Common stock
Footnotes (2)
- [F1]Mr. Fox is an executive director of Penashe Holdings Propriety Limited and may be deemed to have beneficial ownership of these securities to the extent of any indirect pecuniary interest in his distributive shares therein.
- [F2]The original Form 4 report filed on June 11, 2015 incorrectly reported the purchase date and price of the purchase and excluded the direct holdings of the reporting person.